dapsone has been researched along with Purpura, Thrombopenic in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone was discontinued in two patients because of methemoglobinemia." | 1.32 | Dapsone therapy for children with immune thrombocytopenic purpura. ( Delaney, KS; Goldsby, R; Meeker, ND; Slayton, WB; Terrill, KR, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bartakke, SP | 1 |
| Sampagar, AA | 1 |
| Reddy, NA | 1 |
| Kangle, R | 1 |
| Meeker, ND | 1 |
| Goldsby, R | 1 |
| Terrill, KR | 1 |
| Delaney, KS | 1 |
| Slayton, WB | 1 |
| Dutta, TK | 1 |
| Goel, A | 1 |
| Ghotekar, LH | 1 |
| Hamide, A | 1 |
| Badhe, BA | 1 |
| Basu, D | 1 |
| Durand, JM | 2 |
| Lefèvre, P | 2 |
| Hovette, P | 2 |
| Mongin, M | 2 |
| Soubeyrand, J | 1 |
| Issifi, S | 1 |
| Jim, RT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Multicenter Randomized Open-label Controlled Trial Assessing Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia[NCT02627417] | Phase 3 | 216 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dapsone and Purpura, Thrombopenic
| Article | Year |
|---|---|
Dapsone in treatment of chronic idiopathic thrombocytopenic purpura in adults.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Dose-Response | 2001 |
5 other studies available for dapsone and Purpura, Thrombopenic
| Article | Year |
|---|---|
Dapsone Induced Agranulocytosis and Hemolytic Anemia in Immune Thrombocytopenic Purpura.
Topics: Agranulocytosis; Anemia, Hemolytic; Dapsone; Humans; Purpura; Purpura, Thrombocytopenic; Purpura, Th | 2020 |
Dapsone therapy for children with immune thrombocytopenic purpura.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Child; Child, Preschool; Dapso | 2003 |
Dapsone for idiopathic autoimmune thrombocytopenic purpura in elderly patients.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Dapsone; Female; Humans; Male; Platelet Count; Purpura | 1991 |
Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection.
Topics: Adult; Autoimmune Diseases; Dapsone; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle A | 1991 |
Therapeutic use of dapsone in idiopathic thrombocytopenic purpura.
Topics: Dapsone; Female; Humans; Middle Aged; Purpura, Thrombocytopenic | 1989 |